A Clinical Investigation of Recovery Following Hip Resurfacing or Total Hip Arthroplasty

Rheumatoid Arthritis Clinical Trial

Official title:

Functional Recovery Following Hip Resurfacing or Total Hip Arthroplasty in Patients Matched By Age, Gender, and Activity Level

Clinical Trial Details — Status: Withdrawn

Administrative data

• NCT number: NCT00585988
• Other study ID #: 292-U-010
• Status: Withdrawn
• Phase: N/A
• First received: December 21, 2007
• Last updated: June 19, 2017
• Start date: June 2007
• Est. completion date: September 2010

Study information

• Verified date: June 2017
• Source: Zimmer Biomet
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The primary purpose of this study is to compare early functional outcomes in patients undergoing hip resurfacing and total hip arthroplasty with the M2a-Magnum™ using more objective measures of function.

Recruitment information / eligibility

• Status: Withdrawn
• Enrollment: 0
• Est. completion date: September 2010
• Est. primary completion date: September 2009
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Patients requiring hip arthroplasty

Exclusion Criteria:

• Patients with sensory, neurological, or general health conditions that alter perception of their limb in space

• Patients with vestibular disorders

Related Conditions & MeSH terms

• Arthritis
• Arthritis, Rheumatoid
• Osteoarthritis
• Rheumatoid Arthritis
• Traumatic Arthritis

Intervention

Device:
• Hip Resurfacing System
This arm will utilize a hip resurfacing system.
• M2a-Magnum™ Large Metal Articulation
This arm will utilize the M2a-Magnum™ implant system.

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
Biomet Orthopedics, LLC

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Functional Tests		1 year